BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
IOR
Income Opportunity Realty Investors, Inc.
There isn't enough reported data to score IOR yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
IOR Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Stable | |
| N/A | |
| N/A |
IOR's profitability is currently stable. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like IOR.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | โ |
| Current | 12x | $50.51 | โ |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over IOR in the historical PE scenario, which offers more potential upside but is not a forecast.
IOR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $9.77 | -46% |
| Fair | 13x | $11.54 | -37% |
| Expensive | 18x | $16.55 | -9.3% |
| Current | 20x | $18.25 | โ |
Historical ranges are pointers, not guarantees.
IOR's PE is 20x, but its earnings don't support one, so it isn't a reliable read right now.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
IOR Forward outlook
There aren't enough analyst estimates for IOR to show an outlook.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over IOR on earnings, with more consistent year-over-year improvement.
IOR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.92 | -12% |
| Q1 2026 | $0.99 | -8.3% |
| Q4 2025 | $0.98 | -13% |
| Q3 2025 | $1.00 | -32% |
| Q2 2025 | $1.04 | -33% |
| Q1 2025 | $1.08 | -37% |
| Q4 2024 | $1.13 | -33% |
| Q3 2024 | $1.46 | +5.8% |
IOR's earnings per share have fallen from their peak: $0.92 over the past year, against $1.72 in early 2024.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
IOR Quarterly Revenue
IOR and BAC do not have enough comparable growth data to identify a winner.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over IOR on cash generation, producing positive trailing cash flow while its opponent burns cash.
IOR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $25K | +$70K |
| Q1 2026 | -$114K | -178% |
| Q4 2025 | $0 | +$5K |
| Q3 2025 | -$179K | -196% |
| Q2 2025 | -$45K | -$25K |
| Q1 2025 | $147K | -73% |
| Q4 2024 | -$5K | -101% |
| Q3 2024 | $186K | +1760% |
IOR's free cash flow was โ$268,000 over the past year, against $283,000 the year before. Free cash flow isn't a meaningful measure for financial services companies like IOR.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
IOR Net Leverage
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
IOR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.0 | Neutral |
| Stochastic | 46.3 | Neutral |
IOR's weekly RSI is 48 (neutral) and its Stochastic is 46 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over IOR on valuation relative to its sector.
IOR PE vs Financial Services Sector
| Metric | IOR | Sector median | Relative |
|---|---|---|---|
| PE | 20x | 13x | 52% above |
| PE % | 97 | 63 | 34 pts above |
IOR is trading at 20x earnings, a 52% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
IOR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $18.0 | 1.6% above |
| 20 week MA | $19.0 | 3.7% below |
| 50 week MA | $18.4 | 0.9% below |
| 100 week MA | $18.3 | 0.1% below |
| 200 week MA | $16.2 | 13% above |
IOR has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
IOR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.1 | $11.3 | -13% |
| 2021 | $11.3 | $12.1 | +6.4% |
| 2022 | $12.1 | $12.5 | +3.4% |
| 2023 | $12.5 | $13.4 | +7.4% |
| 2024 | $13.4 | $17.8 | +33% |
| 2025 | $17.8 | $17.6 | -1.5% |
| 2026 YTD | $17.6 | $18.3 | +4% |
IOR has the edge over BAC on returns for 2026, with the stronger performance.